Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Tomoko Morita-Ohkubo"'
Autor:
Takuya Awata, Hisakuni Yamashita, Susumu Kurihara, Tomoko Morita-Ohkubo, Yumi Miyashita, Shigehiro Katayama, Keisuke Mori, Shin Yoneya, Masakazu Kohda, Yasushi Okazaki, Taro Maruyama, Akira Shimada, Kazuki Yasuda, Nao Nishida, Katsushi Tokunaga, Asako Koike
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0126789 (2015)
Externí odkaz:
https://doaj.org/article/16f962b1392848f8a6f203cc7173b26a
Autor:
Takuya Awata, Hisakuni Yamashita, Susumu Kurihara, Tomoko Morita-Ohkubo, Yumi Miyashita, Shigehiro Katayama, Keisuke Mori, Shin Yoneya, Masakazu Kohda, Yasushi Okazaki, Taro Maruyama, Akira Shimada, Kazuki Yasuda, Nao Nishida, Katsushi Tokunaga, Asako Koike
Publikováno v:
PLoS ONE, Vol 9, Iss 11, p e111715 (2014)
Elucidation of the genetic susceptibility factors for diabetic retinopathy (DR) is important to gain insight into the pathogenesis of DR, and may help to define genetic risk factors for this condition. In the present study, we conducted a three-stage
Externí odkaz:
https://doaj.org/article/2c8258329fa24c00abd347096f4fcf40
Autor:
Masanobu Kawakami, Tomoko Morita-Ohkubo, Shigehiro Katayama, Takuya Awata, Yoshimasa Aso, Toshihiko Inukai, Yuko Ohno, Natsuko Oshitani, Masafumi Matsuda, Masafumi Kakei, Yoshitaka Akiyama
Publikováno v:
Diabetology international. 8(3)
Both sitagliptin (SIT) and mitiglinide (MIT) can lower postprandial hyperglycemia. The purpose of this study was to examine differences in insulin and glucagon secretion after SIT or MIT administration when similar levels of plasma glucose (PG) were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36be320bb848706791d73d93352b5115
https://pubmed.ncbi.nlm.nih.gov/30603240
https://pubmed.ncbi.nlm.nih.gov/30603240
Autor:
Yoshitaka Akiyama, Tomoko Morita-Ohkubo, Natsuko Oshitani, Yuko Ohno, Yoshimasa Aso, Toshihiko Inukai, Masafumi Kakei, Masanobu Kawakami, Takuya Awata, Shigehiro Katayama, Masafumi Matsuda
Publikováno v:
Diabetology international. 7(1)
Both sitagliptin (SIT) and mitiglinide (MIT) can lower postprandial hyperglycemia. The purpose of this study was to examine differences in insulin and glucagon secretion after SIT or MIT administration when similar levels of plasma glucose (PG) were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69082d98200b622a679edcfdf4af2ace
https://pubmed.ncbi.nlm.nih.gov/30605172
https://pubmed.ncbi.nlm.nih.gov/30605172
Autor:
Masakazu Kohda, Tomoko Morita-Ohkubo, Nao Nishida, Kazuki Yasuda, Asako Koike, Yumi Miyashita, Katsushi Tokunaga, Susumu Kurihara, Taro Maruyama, Shin Yoneya, Shigehiro Katayama, Yasushi Okazaki, Keisuke Mori, Akira Shimada, Hisakuni Yamashita, Takuya Awata
Publikováno v:
PLoS ONE
PLoS ONE, Vol 9, Iss 11, p e111715 (2014)
PLoS ONE, Vol 9, Iss 11, p e111715 (2014)
Elucidation of the genetic susceptibility factors for diabetic retinopathy (DR) is important to gain insight into the pathogenesis of DR, and may help to define genetic risk factors for this condition. In the present study, we conducted a three-stage
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e3f6bd62b8733b160a3328ea263ca81
https://pubmed.ncbi.nlm.nih.gov/25910184
https://pubmed.ncbi.nlm.nih.gov/25910184
Autor:
Akira Shimada, Tetsuro Kobayashi, Hisakuni Yamashita, Shigehiro Katayama, Tomoko Morita-Ohkubo, Kazuma Takahashi, Takuya Awata, Susumu Kurihara, Yoriko Mawatari, Shoichiro Tanaka, Eiji Kawasaki, Hiroshi Ikegami, Taro Maruyama, Yumi Miyashita, Yumiko Kawabata, Nao Nishida
Publikováno v:
Biochemical and biophysical research communications. 437(4)
The role of low-frequency variants in type 1 diabetes (T1D) susceptibility still remains to be clarified. In the present study, we analyzed low-frequency variants of the T1D candidate genes in Japanese. We first screened for protein-changing variants
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::682c9619c1b0e859c1e4a139b468ccda
https://pubmed.ncbi.nlm.nih.gov/23856252
https://pubmed.ncbi.nlm.nih.gov/23856252
Autor:
Hisakuni, Yamashita, Takuya, Awata, Eiji, Kawasaki, Hiroshi, Ikegami, Shoichiro, Tanaka, Taro, Maruyama, Akira, Shimada, Koji, Nakanishi, Kazuma, Takahashi, Tetsuro, Kobayashi, Yumiko, Kawabata, Yumi, Miyashita, Susumu, Kurihara, Tomoko, Morita-Ohkubo, Shigehiro, Katayama
Publikováno v:
Diabetes/metabolism research and reviews. 27(8)
Background We previously reported the associations of human leukocyte antigen (HLA) (DRB1 and DQB1), INS, CTLA4, IL2RA, ERBB3 and CLEC16A with Japanese type 1 diabetes (T1D). In this study, we jointly analysed these loci in addition to IFIH1 and IL7R
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86f272a369d78bf0f5d5bb02a333e09c
https://pubmed.ncbi.nlm.nih.gov/22069271
https://pubmed.ncbi.nlm.nih.gov/22069271